The role of sclerostin in bone homeostasis has been intensively discussed during the last decade, based on insights gained from studies in the very rare monogenic disorders sclerosteosis and van Buchem disease, in which patients have a congenital sclerostin deficiency due to mutations affecting the SOST gene. The gene discussed is SOST; the disease is sclerosteosis.